Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 13, 2023

Primary Completion Date

July 1, 2027

Study Completion Date

December 1, 2027

Conditions

Non Small Cell Lung Cancer

Interventions

PROCEDURE

FAPI PET/CT

The radiopharmaceutical 68Gallium-FAPI-46 (FAPI) is injected intravenously for molecular imaging of FAP expression with FAPI PET/CT.

Trial Locations (1)

RECRUITING

Institut Jules Bordet, Brussels